Bio Green Med Solution, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bio Green Med Solution, Inc. (BGMS) on July 1, 2026. The Company is incorporated in Delaware and its principal executive offices are located in Kuala Lumpur, Malaysia. The report discloses a corporate action regarding its 6% Convertible Exchangeable Preferred Stock.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is the declaration of a quarterly cash dividend of $0.15 per share on the Preferred Stock.
Material Changes
The material event reported is the Board of Directors' declaration of a quarterly cash dividend. This represents a cash outflow obligation to Preferred Stockholders but does not detail changes in operating performance compared to prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure of the dividend event. No unusual items were reported.
Investor Verification Checklist
- Dividend Details: Verify the quarterly cash dividend of $0.15 per share on the 6% Convertible Exchangeable Preferred Stock.
- Payment Schedule: Confirm the payment date of August 1, 2026.
- Record Date: Note the record date of July 23, 2026, for eligibility to receive the dividend.
- Stock Class: Ensure the dividend applies specifically to the Preferred Stock and not the Common Stock (trading symbol BGMS).